Tag: CSL – Seqirus
Advanced vaccine manufacturing in Australia to supply Canada with 15 million pandemic doses
Advanced vaccine manufacturing in Australia is set to support Canada’s pandemic preparedness plans after Australian manufacturer CSL Seqirus secured a contract to supply influenza vaccines in the event of a future global outbreak.
Australia extends life-saving antivenom partnership with PNG
Australia is bolstering its support for Papua New Guinea's health system by renewing its partnership, which includes supplying antivenom doses and training healthcare workers, for an additional three years until 2027.
CSL’s $800 million vaccine manufacturing facility in Melbourne nears completion
CSL Seqirus has reached a major milestone in the construction of its new cutting-edge manufacturing facility for vaccine and antivenom manufacturing.Â
TGA approves domestic manufacture of AstraZeneca vaccine
CSL has been given the nod by the Therapeutic Goods Administration (TGA) to commence the manufacture of the AstraZeneca COVID-19 Vaccine (ChAdOx1-S) in Australia.
TGA’s...
Featured Article
APS Industrial expands regional footprint with Control Technologies acquisition
APS Industrial (APS) is expanding its regional presence through the acquisition of Albury-based Control Technologies, a move the industrial products supplier said will strengthen its local service capability and support further investment in warehousing, stockholding and technical support.
